LYZ and amyloidosis: We have previously suggested that the onset of lysozyme amyloidosis may be linked to the inability of the UPR to target for degradation the entire population of amyloidogenic variants, allowing a proportion of these species to aggregate and accumulate in the body as amyloid deposits [14].